Supplied strictly for in-vitro and laboratory research. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher handling these materials per applicable regulations and safe lab practice.
TB-500 is a synthetic version of the central active fragment of thymosin beta-4. It is studied for its involvement in actin binding, cell migration, and tissue remodeling, with much of the research interest centered on wound-healing and angiogenesis models. As a defined synthetic fragment it gives researchers a consistent reagent for interrogating cytoskeletal behavior.
Thymosin beta-4 was first isolated from thymus tissue in the early 1980s. Its actin-binding region was later synthesized as TB-500, which became a widely used reagent for studying cytoskeletal dynamics and repair-associated signaling. Isolating the active fragment allowed researchers to work with a smaller, more tractable molecule while retaining the properties most relevant to remodeling research.
TB-500 has been studied across structural, vascular, and epithelial models for activity on G-actin sequestration, F-actin dynamics, angiogenic signaling, and re-epithelialization kinetics. Because actin regulation sits upstream of both migration and structural repair, TB-500 is treated as a probe for the earliest mechanical stages of tissue remodeling. Its consistency across model systems is what makes it a durable tool for characterizing cytoskeletal and angiogenic pathways in the laboratory.
Manufactured in a controlled U.S. facility under strict compounding standards.
Every batch third-party tested with HPLC and mass spectrometry.
Orders dispatched same-day from our U.S. facility.
Reach out and get a response within minutes.
Everything you need to know about our products and processes.